Exogems

Epalinges, Switzerland

Exogems is a biotechnology company that produces therapeutic exosomes from adipose tissue.

$590K raised

Aug 2024

Seed

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Exogems

How much funding has Exogems raised?

Exogems has raised $590K in total funding. The most recent round was Seed. The last funding was announced in August 2024.

Where is Exogems headquartered?

Exogems is headquartered in Epalinges, Switzerland.

What does Exogems do?

Exogems is a biotechnology company that produces therapeutic exosomes from adipose tissue.

What stage is Exogems at?

Exogems is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 29, 2024.

MLA

"Exogems — Funding & Investors." VCBacked, August 29, 2024, https://www.vcbacked.co/company/exogems. Accessed July 2, 2026.

APA

VCBacked. (2024). Exogems — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/exogems

Wikipedia (cite web)

{{cite web |title=Exogems — Funding & Investors |url=https://www.vcbacked.co/company/exogems |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 29, 2024.